Trial intelligence / Profile preview

Microneedle Sensing of Beta-lactam Antibiotics

NCT03847610Phase 1Completed

Sponsor
Imperial College London
Start
Apr 2018
Primary completion
Aug 2018
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Imperial College London. Primary endpoint: Assessment of the Biosensors Ability to Track Phenoxymethylpenicillin Concentrations Compared to Observations Made by Microdialysis and Blood Sampling at 12 hours. Started Apr 2018; status: completed.

Beyond the preview

Go deeper on NCT03847610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03847610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call